2024 annual financial data
C4 Therapeutics, Inc. 2024 Operating margin
C4 Therapeutics, Inc. 2024 operating margin with verified reported values.
Direct answer
Operating margin was -336.15%.
Operating income was -119,614,000 USD and net income was -105,316,000 USD.
Operating cash flow was -65,157,000 USD.
Get free C4 Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 35,584,000 USD
- Operating income
- -119,614,000 USD
- Net income
- -105,316,000 USD
- Operating cash flow
- -65,157,000 USD